• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 QSAR 和分子建模研究设计潜在的抗肿瘤 PARP-1 抑制剂。

Design of potential anti-tumor PARP-1 inhibitors by QSAR and molecular modeling studies.

机构信息

Institute of Petroleum Engineering, School of Chemical Engineering, College of Engineering, University of Tehran, Tehran, Iran.

Laboratory of Bioinformatics and Drug Design (LBD), Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.

出版信息

Mol Divers. 2021 Feb;25(1):263-277. doi: 10.1007/s11030-020-10063-9. Epub 2020 Mar 5.

DOI:10.1007/s11030-020-10063-9
PMID:32140890
Abstract

Poly ADP-ribose polymerase-1 (PARP-1) inhibitors have been recognized as new agents for the treatment of patients with breast cancer type 1 (BRCA1) disorders. The quantitative structure-activity relationships (QSAR) technique was used in order to achieve the required medicines for anticancer activity easier and faster. In this study, the QSAR method was developed to predict the half-maximal inhibitory concentration (IC) of 51 1H-benzo[d]immidazole-4-carboxamide derivatives by genetic algorithm-multiple linear regression (GA-MLR) and least squares-support vector machine (LS-SVM) methods. Results in the best QSAR model represented the coefficient of leave-one-out cross-validation (Q ) = 0.971, correlation coefficient (R) = 0.977, Fisher parameter (F) = 259.016 and root mean square error (RMSE) = 0.095, respectively, which indicated that the LS-SVM model had a good potential to predict the pIC (9 - log(IC nM)) values compared with other modeling methods. Also, molecular docking evaluated interactions between ligands and enzyme and their free energy of binding were calculated and used as descriptors. Molecular docking and the QSAR study completed each other. The results represented that the final model can be useful to design some new inhibitors. So, the knowledge of the QSAR modeling and molecular docking was used in pIC prediction and 51 new compounds were developed as PARP-1 inhibitors that 9 compounds had the best-proposed values for pIC. The maximum enhancement of the inhibitory activity of compounds was 33.394%.

摘要

聚 ADP-核糖聚合酶-1(PARP-1)抑制剂已被认为是治疗乳腺癌 1 型(BRCA1)疾病患者的新型药物。为了更容易、更快地获得具有抗癌活性的所需药物,采用了定量构效关系(QSAR)技术。在这项研究中,通过遗传算法-多元线性回归(GA-MLR)和最小二乘支持向量机(LS-SVM)方法,开发了 QSAR 方法来预测 51 个 1H-苯并[d]咪唑-4-甲酰胺衍生物的半最大抑制浓度(IC)。最佳 QSAR 模型的结果代表了留一交叉验证系数(Q)= 0.971、相关系数(R)= 0.977、Fisher 参数(F)= 259.016 和均方根误差(RMSE)= 0.095,分别表示与其他建模方法相比,LS-SVM 模型具有良好的预测 pIC(9-log(IC nM))值的潜力。此外,分子对接评估了配体与酶之间的相互作用及其结合自由能,并将其用作描述符。分子对接和 QSAR 研究相互补充。结果表明,最终模型可用于设计一些新的抑制剂。因此,QSAR 建模和分子对接的知识用于 pIC 预测,开发了 51 种新的化合物作为 PARP-1 抑制剂,其中 9 种化合物具有最佳的 pIC 值。化合物的抑制活性最大增强了 33.394%。

相似文献

1
Design of potential anti-tumor PARP-1 inhibitors by QSAR and molecular modeling studies.通过 QSAR 和分子建模研究设计潜在的抗肿瘤 PARP-1 抑制剂。
Mol Divers. 2021 Feb;25(1):263-277. doi: 10.1007/s11030-020-10063-9. Epub 2020 Mar 5.
2
A simple and robust model to predict the inhibitory activity of α-glucosidase inhibitors through combined QSAR modeling and molecular docking techniques.通过组合 QSAR 建模和分子对接技术,建立一个简单而强大的模型来预测α-葡萄糖苷酶抑制剂的抑制活性。
Mol Divers. 2021 Aug;25(3):1811-1825. doi: 10.1007/s11030-020-10164-5. Epub 2021 Feb 9.
3
QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors.使用对接衍生分子描述符对HIV-1蛋白酶抑制活性进行定量构效关系预测。
J Theor Biol. 2015 Mar 21;369:13-22. doi: 10.1016/j.jtbi.2015.01.008. Epub 2015 Jan 16.
4
Molecular modeling studies on benzimidazole carboxamide derivatives as PARP-1 inhibitors using 3D-QSAR and docking.使用 3D-QSAR 和对接技术对苯并咪唑甲酰胺衍生物作为 PARP-1 抑制剂的分子建模研究。
Chem Biol Drug Des. 2011 Sep;78(3):333-52. doi: 10.1111/j.1747-0285.2011.01139.x. Epub 2011 Jul 29.
5
Structure-based design of new poly (ADP-ribose) polymerase (PARP-1) inhibitors.基于结构的新型多聚(ADP-核糖)聚合酶(PARP-1)抑制剂的设计。
Mol Divers. 2017 Aug;21(3):655-660. doi: 10.1007/s11030-017-9754-7. Epub 2017 Jun 26.
6
Multiple receptor conformation docking, dock pose clustering and 3D QSAR studies on human poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors.人聚(ADP - 核糖)聚合酶-1(PARP - 1)抑制剂的多受体构象对接、对接姿势聚类及三维定量构效关系研究
J Recept Signal Transduct Res. 2014 Oct;34(5):417-30. doi: 10.3109/10799893.2014.917323. Epub 2014 Jul 21.
7
Structural Requirements of Some 2-(1-Propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide Derivatives as Poly (ADP-Ribose) Polymerase (PARP) for the Treatment of Cancer: QSAR Approach.某些2-(1-丙基哌啶-4-基)-1H-苯并咪唑-4-甲酰胺衍生物作为聚(ADP-核糖)聚合酶(PARP)用于癌症治疗的结构要求:定量构效关系方法
Interdiscip Sci. 2016 Mar;8(1):11-22. doi: 10.1007/s12539-015-0015-0. Epub 2015 Jul 24.
8
Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.通过比较和经过验证的计算建模技术和分子动力学模拟,逐步开发出不同 PARP-1 抑制剂的结构-活性关系。
J Biomol Struct Dyn. 2015;33(8):1756-79. doi: 10.1080/07391102.2014.969772. Epub 2014 Oct 28.
9
Discovery of 2-(1-(3-(4-Chloroxyphenyl)-3-oxo- propyl)pyrrolidine-3-yl)-1-benzo[d]imidazole-4-carboxamide: A Potent Poly(ADP-ribose) Polymerase (PARP) Inhibitor for Treatment of Cancer.发现 2-(1-(3-(4-氯苯氧基)-3-氧代丙基)吡咯烷-3-基)-1-苯并[d]咪唑-4-甲酰胺:一种用于癌症治疗的有效的多聚(ADP-核糖)聚合酶(PARP)抑制剂。
Molecules. 2019 May 17;24(10):1901. doi: 10.3390/molecules24101901.
10
Rational Design of Colchicine Derivatives as anti-HIV Agents via QSAR and Molecular Docking.通过定量构效关系(QSAR)和分子对接技术进行秋水仙碱衍生物作为抗HIV药物的合理设计
Med Chem. 2019;15(4):328-340. doi: 10.2174/1573406414666180924163756.

引用本文的文献

1
De Novo Design of Imidazopyridine-Tethered Pyrazolines That Target Phosphorylation of STAT3 in Human Breast Cancer Cells.靶向人乳腺癌细胞中STAT3磷酸化的咪唑并吡啶连接的吡唑啉的从头设计
Bioengineering (Basel). 2023 Jan 24;10(2):159. doi: 10.3390/bioengineering10020159.
2
PARP1pred: a web server for screening the bioactivity of inhibitors against DNA repair enzyme PARP-1.PARP1pred:一个用于筛选针对DNA修复酶PARP-1的抑制剂生物活性的网络服务器。
EXCLI J. 2023 Jan 5;22:84-107. doi: 10.17179/excli2022-5602. eCollection 2023.
3
Opportunities and challenges in application of artificial intelligence in pharmacology.

本文引用的文献

1
3D QSAR studies, molecular docking and ADMET evaluation, using thiazolidine derivatives as template to obtain new inhibitors of PIM1 kinase.基于噻唑烷衍生物模板的 3D QSAR 研究、分子对接和 ADMET 评估,以获得新的 PIM1 激酶抑制剂。
Comput Biol Chem. 2018 Jun;74:201-211. doi: 10.1016/j.compbiolchem.2018.03.008. Epub 2018 Mar 12.
2
Application of molecular docking for the degradation of organic pollutants in the environmental remediation: A review.应用分子对接技术降解环境修复中有机污染物的研究进展:综述
Chemosphere. 2018 Jul;203:139-150. doi: 10.1016/j.chemosphere.2018.03.179. Epub 2018 Mar 27.
3
BRCA1 mutation spectrum, functions, and therapeutic strategies: The story so far.
人工智能在药理学应用中的机遇与挑战。
Pharmacol Rep. 2023 Feb;75(1):3-18. doi: 10.1007/s43440-022-00445-1. Epub 2023 Jan 9.
4
A multi-task FP-GNN framework enables accurate prediction of selective PARP inhibitors.一种多任务FP-GNN框架能够准确预测选择性PARP抑制剂。
Front Pharmacol. 2022 Oct 11;13:971369. doi: 10.3389/fphar.2022.971369. eCollection 2022.
5
Comparative differential cytotoxicity of clinically used SERMs in human cancer lines of different origin and its predictive molecular docking studies of key target genes involved in cancer progression and treatment responses.临床使用的选择性雌激素受体调节剂在不同来源的人类癌细胞系中的比较差异细胞毒性及其对癌症进展和治疗反应中关键靶基因的预测性分子对接研究。
Curr Res Pharmacol Drug Discov. 2021 Dec 31;3:100080. doi: 10.1016/j.crphar.2021.100080. eCollection 2022.
6
A simple and robust model to predict the inhibitory activity of α-glucosidase inhibitors through combined QSAR modeling and molecular docking techniques.通过组合 QSAR 建模和分子对接技术,建立一个简单而强大的模型来预测α-葡萄糖苷酶抑制剂的抑制活性。
Mol Divers. 2021 Aug;25(3):1811-1825. doi: 10.1007/s11030-020-10164-5. Epub 2021 Feb 9.
7
Dehydroabietylamine-based thiazolidin-4-ones and 2-thioxoimidazolidin-4-ones as novel tyrosyl-DNA phosphodiesterase 1 inhibitors.基于去氢枞胺的噻唑烷-4-酮和 2-硫代亚氨唑烷-4-酮类化合物作为新型酪氨酰 DNA 磷酸二酯酶 1 抑制剂。
Mol Divers. 2021 Nov;25(4):2389-2397. doi: 10.1007/s11030-020-10132-z. Epub 2020 Aug 24.
BRCA1基因的突变谱、功能及治疗策略:迄今为止的情况。
Curr Probl Cancer. 2018 Mar-Apr;42(2):189-207. doi: 10.1016/j.currproblcancer.2018.01.001. Epub 2018 Jan 8.
4
NF90 regulates PARP1 mRNA stability in hepatocellular carcinoma.NF90调节肝癌中PARP1 mRNA的稳定性。
Biochem Biophys Res Commun. 2017 Jun 17;488(1):211-217. doi: 10.1016/j.bbrc.2017.05.037. Epub 2017 May 6.
5
Rational design, synthesis, pharmacophore modeling, and docking studies for identification of novel potent DNA-PK inhibitors.用于鉴定新型强效DNA依赖蛋白激酶(DNA-PK)抑制剂的合理设计、合成、药效团建模及对接研究
Bioorg Chem. 2017 Jun;72:234-247. doi: 10.1016/j.bioorg.2017.04.014. Epub 2017 May 2.
6
Discovery of 2-substituted 1H-benzo[d]immidazole-4-carboxamide derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors with in vivo anti-tumor activity.发现2-取代的1H-苯并[d]咪唑-4-甲酰胺衍生物作为具有体内抗肿瘤活性的新型聚(ADP-核糖)聚合酶-1抑制剂。
Eur J Med Chem. 2017 May 26;132:26-41. doi: 10.1016/j.ejmech.2017.03.013. Epub 2017 Mar 18.
7
DNA Damage Repair and the Emerging Role of Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapeutics.DNA损伤修复与聚(ADP-核糖)聚合酶抑制在癌症治疗中的新作用
Clin Ther. 2016 Jul;38(7):1577-88. doi: 10.1016/j.clinthera.2016.06.006. Epub 2016 Jun 29.
8
A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules.用煮鸡蛋预测小分子的胃肠道吸收和脑渗透
ChemMedChem. 2016 Jun 6;11(11):1117-21. doi: 10.1002/cmdc.201600182. Epub 2016 May 24.
9
2D and 3D QSAR models for identifying diphenylpyridylethanamine based inhibitors against cholesteryl ester transfer protein.用于鉴定基于二苯基吡啶基乙胺的胆固醇酯转移蛋白抑制剂的二维和三维定量构效关系模型
Bioorg Med Chem Lett. 2015 Oct 15;25(20):4487-95. doi: 10.1016/j.bmcl.2015.08.080. Epub 2015 Aug 29.
10
Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predicts Poor Survival of Breast Carcinoma Patients.DNA损伤反应分子PARP1、γH2AX、BRCA1和BRCA2的表达预示着乳腺癌患者的不良生存结局。
Transl Oncol. 2015 Aug;8(4):239-49. doi: 10.1016/j.tranon.2015.04.004.